Literature DB >> 8047808

Chronic nonatropic ('superficial') gastritis increases the risk of gastric carcinoma. A case-control study.

P Sipponen1, M Riihelä, H Hyvärinen, K Seppälä.   

Abstract

Atrophic gastritis is a well-known risk condition for gastric carcinoma (GCA). Less is known about the risk of GCA in subjects with nonatrophic ('superficial') gastritis. To investigate this, we estimated the risk of GCA in patients with nonatrophic gastritis as compared with that in subjects with normal, nongastritic mucosa. Two hundred and forty-three consecutive GCA patients and 1408 non-GCA outpatients (controls), for whom histologic data (endoscopic biopsy) of gastric mucosa was available, were included in the study. To estimate the relative risk (RR) of GCA, the odds ratio of gastritis was calculated in patients and controls by adjusting for age and sex. The RR (95% confidence interval) of GCA in patients with nonatrophic antral gastritis and with nonatrophic pangastritis was 1.8 (1.2-2.7) and 2.5 (1.4-4.3), respectively. Correspondingly, the risks of GCA were 9.1 (5.4-15.5) in patients with atrophic antral gastritis or pangastritis (atrophy of any degree) and 4.4 (1.9-10) in those with severe atrophic corpus gastritis (severe corpus limited atrophy of 'A type'). In nonatrophic gastritis the risk of diffuse-type GCA was emphasized, whereas the risk of intestinal-type GCA was emphasized in patients with atrophic gastritis. These results indicate that an increased risk of GCA is not confined to subjects with atrophic gastritis but is also slightly but significantly increased in patients with chronic nonatrophic gastritis.

Entities:  

Mesh:

Year:  1994        PMID: 8047808     DOI: 10.3109/00365529409094845

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  13 in total

Review 1.  Diet, H pylori infection and gastric cancer: evidence and controversies.

Authors:  Alba Rocco; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

2.  Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow up study.

Authors:  A Kokkola; R Haapiainen; F Laxén; P Puolakkainen; E Kivilaakso; J Virtamo; P Sipponen
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

3.  Gastritis staging in clinical practice: the OLGA staging system.

Authors:  Massimo Rugge; Alberto Meggio; Gianmaria Pennelli; Francesco Piscioli; Luciano Giacomelli; Giovanni De Pretis; David Y Graham
Journal:  Gut       Date:  2006-12-01       Impact factor: 23.059

Review 4.  Proton pump inhibitors and H. pylori infection: why the concern?

Authors:  W M Weinstein
Journal:  Curr Gastroenterol Rep       Date:  1999-12

5.  Analysis of cell damage and proliferation in Helicobacter pylori-infected human gastric mucosa from patients with gastric adenocarcinoma.

Authors:  N Yabuki; H Sasano; M Tobita; A Imatani; T Hoshi; K Kato; S Ohara; S Asaki; T Toyota; H Nagura
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

Review 6.  Role of Helicobacter pylori in gastrointestinal disease: implications for primary care of a revolution in management of dyspepsia.

Authors:  B C Delaney
Journal:  Br J Gen Pract       Date:  1995-09       Impact factor: 5.386

Review 7.  Acid, protons and Helicobacter pylori.

Authors:  G Sachs; K Meyer-Rosberg; D R Scott; K Melchers
Journal:  Yale J Biol Med       Date:  1996 May-Jun

Review 8.  Bacterial infection as a cause of cancer.

Authors:  J Parsonnet
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

9.  The incidence of neoplasia in patients with autoimmune metaplastic atrophic gastritis: a renewed call for surveillance.

Authors:  Nadim Mahmud; Kristen Stashek; Bryson W Katona; Rashmi Tondon; Stuti G Shroff; Robert Roses; Emma E Furth; David C Metz
Journal:  Ann Gastroenterol       Date:  2018-11-08

10.  Identification of Gastritis Subtypes by Convolutional Neuronal Networks on Histological Images of Antrum and Corpus Biopsies.

Authors:  Georg Steinbuss; Katharina Kriegsmann; Mark Kriegsmann
Journal:  Int J Mol Sci       Date:  2020-09-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.